ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

Role of Hemostatic System in Cancer, Inflammation and Immunity » Platelets and Cancer

Theme Navigation

  • ISTH 2021 Congress
    • Role of Hemostatic System in Cancer, Inflammation and Immunity
      • Platelets and Cancer

Abstract Number: PB0751

A Role of Possible Synergistic Effect of P Selectin Glycoprotein Ligand 1 Polymorphism and Antiphosholipid Antibodies on Thrombosis in Myeloproliferative Neoplasia Patients

R. Dambrauskienė1, R. Gerbutavičius1, R. Vadeikienė1, R. Gerbutavičius2, R. Ugenskienė1, M. Rudžianskienė1, E. Juozaitytė1, D. Remeikienė1, R. Gerbutavičienė3, R. Paukštaitienė4

Abstract Number: PB0748

Anti-platelet Drugs and Risk of Intracranial Hemorrhage in Patients with Metastatic Brain Tumors

E. Miller1, R. Patell2, E. Uhlmann3, S. Ren4, H. Southard2, P. Elavalakanar2, G. Weber5, D. Neuberg4, J. Zwicker2

Abstract Number: PB0754

Antiplatelet and Cytostatic Properties of Nilotinib Synthetic Analogues

L.M. Pechlivani1, N. Ntemou2, P. Voulgari2, D. Pantazi1, K. Skobridis2, A.D. Tselepis1

Abstract Number: LPB0072

Aspirin vs P2RY12-Inhibitors to Reduce Cancer Associated Thrombosis and Tumor Growth in Digestive Cancers

A.L. Palacios Acedo1, S. Mezouar1, D. Mege1,2, L. Crescence1, C. Dubois1, L. Panicot-Dubois1

Abstract Number: PB0753

Association of Platelet Count and Coagulopathy before, during and Post Chemotherapy: Is it Worth Doing?

N. Anwar1, N. Fatima1, H.-u. Mujtaba1, T. Shamsi1

Abstract Number: PB0755

Characteristics and Management of a Series of TAFRO Syndrome

X. Ye1

Abstract Number: PB0752

Chemotherapy Induced Thrombocytopenia: Is it Inducing Additional Social, Economic and Clinical Burden?

N. Anwar1, N. Fatima1, H.-u.- Mujtaba1, T. Shamsi1

Abstract Number: PB0757

Chemotherapy-induced Thrombocytopenia and Platelet Transfusions in Hematology/Oncology Practice

L. Hambardzumyan1,2, A. Movsisyan1,2, M. Badikyan2,3, N. Martirosyan2,3, H. Khachatryan1,2, A. Sevoyan2, H. Grigoryan1,1,2, N. Martirosyan2,4, G. Tamamyan1,2,4, S. Danielyan2

Abstract Number: PB0756

Chronic Myeloid Leukemia with Extreme Thrombocytosis as Unusual Initial Presentation

N. Petkova1

Abstract Number: LPB0120

Correlation between Procoagulant Platelets and Hypercoagulability in Lung Cancer Patients

M. Schreuder1,2, E.E. Ramsay1,2, H. Campbell3, J. Simes1, M. Boyer4, A. Joshua5,6,7, V. Chin5,6,7, J. Young8,9,10, B. Brown2, V.M. Chen3,11, P.J. Hogg2,12

Abstract Number: PB0750

Correlation between Serum PDGF-CC Levels with Clinical Stage of Colorectal Cancer

E. Sundarita1, M. Syahrir1, N. Djamaludin1, Y.D. Andayani1, Z. Zulaikha1, E. Syahriana1

Abstract Number: PO151

Essential Thrombocythemia with Deep Vein Thrombosis and Recurrent Gangrene Pedis

H. Gustian1.

Abstract Number: PB0758

Hemostatic Evaluation by Thromboelastography in Patients from a Peruvian Oncologic Center

L.F. Motta Rosada1, R.M. Rodriguez Torres1, N.V. Herrera Valverde2

Abstract Number: PB0749

Native Rotational Thromboelastometry in Chemotherapy Induced Thrombocytopenia

A.-M. Hulshof1, F. Heubel-Moenen1, F. Tjahjadi2, C. Saelmans2, T. van de Berg2, E. Beckers1, T. Hackeng2, Y. Henskens1

Abstract Number: OC 41.1

Platelet microRNAs Inhibit Primary Tumor Growth via Broad Modulation of Tumor Cell mRNA Expression in Ectopic Pancreatic Cancer in Mice

J.G. Wurtzel1, S. Lazar1, I. Astsaturov2, A.S. Weyrich3, J.W. Rowley3, L. Goldfinger1

Abstract Number: PB0747

Platelets Promoted Malignancy Involving Exosomal HMGB1

J.-D. Wang1, C.-J. Chen1, S.-L. Liao1, S.-W. Huang2

Abstract Number: OC 58.4

Platelets Stimulate Programmed Death-ligand 1 Expression by Cancer Cells: Inhibition by Anti-platelet Drugs

A. Asgari1, G. Lesyk1, E. Poitras2, N. Govindasamy3, K. Terry2, R. To1, V. Back1, J. Rudzinski3, J. Lewis3, P. Jurasz1,2

Abstract Number: LPB0121

Quantitative and Qualitative Changes in Platelet Traits of Sunitinib-treated Patients with Renal Cell Carcinoma in Relation to Circulating Sunitinib Levels: A Proof-of-Concept Study

B.M. Tullemans1, S.L. Brouns1, F. Swieringa1, S. Sabrkhany1, F.W. van den Berkmortel2, N.A. Peters3, P. de Bruijn4, S.L. Koolen4,5, J.W. Heemskerk1, M.J. Aarts6, M.J. Kuijpers1

Abstract Number: OC 58.1

The “Double-edged Sword”: The Role of LMWPTP in Platelet Hyperactivity in Cancer Patients

A.V.S. Faria1,2, B. Yu2, S.S. Andrade3, M. Peppelenbosch2, G. Fuhler2, C.V. Ferreira-Halder1

Abstract Number: PB0746

Tumor Cell-induced Platelet Aggregation is Sustained by Platelet Entrapment into the Fibrin Network Formed by Thrombin

I. Tesakov1, A. Filkova2,3,4, A. Deputatova4, A. Korneichuk4, S. Obydennyi2,3, I. Kireev5, M. Panteleev2,3,4, A. Sveshnikova2,3,4

« View all themes from the ISTH 2021 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley